Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Millipore and HyClone Align to Optimize Biopharmaceutical Drug Production

By Pharmaceutical Processing | March 2, 2004

Millipore Corporation and HyClone Laboratories have announced the formation of a bioprocessing alliance. HyClone is a global leader in cell culture consumables and disposable bioprocess liquid containment products and a subsidiary of Fisher Scientific International Inc. (NYSE: FSH), a world leader in serving science. The alliance between Millipore and HyClone combines the critical elements required for value-added disposable manufacturing solutions. Biopharmaceutical manufacturers will have one supplier contact for the design, development, and validation support of disposable manufacturing systems combining HyClone bioprocess containers with various Millipore disposable separation products.

Disposable processing systems received initial acceptance as cost-saving measures. Now, proven benefits include not only lower costs, but also less down-time, enhanced process security, greater process flexibility, and the capacity to facilitate greater speed-to-market. Disposable manufacturing also enables companies to run multiple products in a single plant without risking cross-contamination.

“Both Millipore and HyClone have worked with pioneering biopharmaceutical companies to validate single-use disposable systems. Our collaborative efforts indicate that these companies are committing significant resources to the validation and implementation of disposable strategies,” said Susan Vogt, President of Millipore’s BioPharmaceutical division.

Through this relationship, HyClone and Millipore will jointly address customers’ needs for disposable combined products for pilot plant, process development and production applications. Future innovations required to meet evolving industry demands for combined products will come through the alliance partners’ complementary R&D efforts in separation technology, connectology, and in validation, and applications engineering.

“This alliance delivers the competencies and reliability required to support the continuing acceptance and growth of disposable biopharma manufacturing,” said Leland Foster, President and Chief Executive Officer of Fisher Scientific’s Biochemicals Group. “The expertise both companies bring to the effort can speed the drug development process and enhance customer process economics.”

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE